CDMO Network

Overview

CDMO Network is a neutral coordination layer for biomanufacturing operated by Berube BioVentures, LLC. Rather than executing manufacturing directly, the platform routes biotechnology, pharmaceutical, and life science companies to appropriate CDMO partners based on modality, development stage, scale, geography, timeline, technical fit, regulatory expectations, and commercial alignment.

Core Value Proposition

The platform addresses structural friction in biomanufacturing by connecting discovery, development, GMP manufacturing, analytical testing, fill-finish, quality, regulatory support, tech transfer, logistics, and supply coordination through one structured route. Programs are matched to best-fit partners rather than forced into bundled compromises, reducing mismatched capabilities, unclear scopes, slow introductions, opaque quoting, weak transfer planning, quality drift, and fragmented vendor management.

Capability Coverage

Discovery & Early Research: Cell line and strain engineering, process development

Manufacturing: Drug substance manufacturing, drug product and fill-finish, GMP manufacturing

Analytics & Quality: Analytical and QC testing, formulation and stability studies, regulatory, quality and compliance support

Scale & Transfer: Tech transfer and scale-up, supply chain and logistics coordination, packaging and labelling

Digital Infrastructure: Structured RFQ management, capability mapping, continuity management across sites and vendors

Modalities Supported

Antibodies and engineered binders, recombinant proteins and complex biologics, genetic medicines and nucleic acids, viral vectors and platforms, cell therapies, vaccines

Industries Served

Biotechnology, biopharmaceuticals, cell and gene therapy, diagnostics, emerging and hybrid applications, enzymes and industrial biologics, food/nutrition/alternative proteins, microbiome and live biotherapeutics, research tools and life science reagents, public sector and institutional programs, vaccines